(Q71247369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

1 reference

J A Child

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

D L Barnard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

S C Cartwright

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

I Lauder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

A V Simmons

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

J Stone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

J Thorogood

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

153-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

17 October 2019

cites work

1 reference

12 December 2020

The management of generalised grade 2 non-Hodgkin's lymphomas (Report no 18)

1 reference

12 December 2020

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

1 reference

12 December 2020

Advanced diffuse histiocytic lymphoma, a potentially curable disease

1 reference

12 December 2020

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

1 reference

12 December 2020

New approaches to the management of patients with non-Hodgkin's lymphoma of high-grade pathology. First Gordon Hamilton-Fairley memorial lecture

1 reference

12 December 2020

Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomas

1 reference

12 December 2020

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

12 December 2020

High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement

1 reference

12 December 2020

Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma

1 reference

12 December 2020

Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology

1 reference

12 December 2020

Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP)

1 reference

12 December 2020

Chemotherapy of the non-Hodgkin's lymphomas

1 reference

12 December 2020

Prognostic significance of the Lukes and Collins classification in patient treated with COMLA

1 reference

12 December 2020

Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)

1 reference

12 December 2020

Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688970%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference